Scholars@Duke

Topical bevacizumab therapy for corneal neovascularization.

Publication ,  Journal Article
DeStafeno, JJ; Kim, T
Published in: Arch Ophthalmol
June 2007
Published version (DOI) Link to item

Duke Scholars

Terry Kim
Author Terry Kim Ophthalmology, Corneal Diseases

Published In

Arch Ophthalmol

DOI

10.1001/archopht.125.6.834

ISSN

0003-9950

Publication Date

June 2007

Volume

125

Issue

6

Start / End Page

834 / 836

Location

United States

Related Subject Headings

  • Visual Acuity
  • Vascular Endothelial Growth Factor A
  • Treatment Outcome
  • Ophthalmology & Optometry
  • Male
  • Humans
  • Corneal Neovascularization
  • Bevacizumab
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal
 

Citation

APA
Chicago
ICMJE
MLA
NLM
DeStafeno, J. J., & Kim, T. (2007). Topical bevacizumab therapy for corneal neovascularization. Arch Ophthalmol, 125(6), 834–836. https://doi.org/10.1001/archopht.125.6.834
DeStafeno, John J., and Terry Kim. “Topical bevacizumab therapy for corneal neovascularization.” Arch Ophthalmol 125, no. 6 (June 2007): 834–36. https://doi.org/10.1001/archopht.125.6.834.
DeStafeno JJ, Kim T. Topical bevacizumab therapy for corneal neovascularization. Arch Ophthalmol. 2007 Jun;125(6):834–6.
DeStafeno, John J., and Terry Kim. “Topical bevacizumab therapy for corneal neovascularization.” Arch Ophthalmol, vol. 125, no. 6, June 2007, pp. 834–36. Pubmed, doi:10.1001/archopht.125.6.834.
DeStafeno JJ, Kim T. Topical bevacizumab therapy for corneal neovascularization. Arch Ophthalmol. 2007 Jun;125(6):834–836.

Published In

Arch Ophthalmol

DOI

10.1001/archopht.125.6.834

ISSN

0003-9950

Publication Date

June 2007

Volume

125

Issue

6

Start / End Page

834 / 836

Location

United States

Related Subject Headings

  • Visual Acuity
  • Vascular Endothelial Growth Factor A
  • Treatment Outcome
  • Ophthalmology & Optometry
  • Male
  • Humans
  • Corneal Neovascularization
  • Bevacizumab
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal